We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+15.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2B
AUM Growth
+$280M
Cap. Flow
+$118M
Cap. Flow %
5.92%
Top 10 Hldgs %
28.16%
Holding
148
New
13
Increased
87
Reduced
14
Closed
14

Top Buys

Rank Stock Value
1
ATHN
Athenahealth, Inc.
ATHN
+$16.4M
2
CRUS icon
Cirrus Logic
CRUS
+$15.5M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$15.4M
4
CSIQ icon
Canadian Solar
CSIQ
+$13.8M
5
XPO icon
XPO
XPO
+$12.4M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$27.7M
2
CMRX
Chimerix, Inc.
CMRX
+$20.4M
3
SUNE
SUNEDISON, INC COM
SUNE
+$20.3M
4
TERP
TerraForm Power, Inc
TERP
+$17.7M
5
CGNX icon
Cognex
CGNX
+$7.05M

Sector Composition

Rank Sector Weight
1 Healthcare 30.11%
2 Technology 22.93%
3 Consumer Discretionary 12.85%
4 Industrials 7.77%
5 Real Estate 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGTX icon
76
TG Therapeutics
TGTX
$8.19B
$6.41M 0.32%
537,600
+161,800
+43% +$2.04M
MCRB icon
77
Seres Therapeutics
MCRB
$46.3M
$6.25M 0.31%
8,910
+3,533
+66% +$2.32M
DVAX
78
DELISTED
Dynavax Technologies
DVAX
$6.04M 0.3%
250,000
-30,700
-11% -$769K
XLRN
79
DELISTED
Acceleron Pharma
XLRN
$6.02M 0.3%
123,500
+36,400
+42% +$1.31M
CEMP
80
DELISTED
Cempra, Inc.
CEMP
$5.76M 0.29%
184,900
+28,100
+18% +$782K
RGEN icon
81
Repligen
RGEN
$7.03B
$5.71M 0.29%
202,000
+23,600
+13% +$681K
AGTC
82
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.69M 0.28%
279,100
+28,600
+11% +$441K
VYGR icon
83
Voyager Therapeutics
VYGR
$189M
$5.47M 0.27%
+250,000
New +$5.76M
ORA icon
84
Ormat Technologies
ORA
$5.94B
$5.47M 0.27%
+150,000
New +$5.46M
STML
85
DELISTED
Stemline Therapeutics, Inc.
STML
$5.37M 0.27%
851,400
+116,400
+16% +$945K
GBT
86
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.33M 0.27%
165,000
+149,521
+966% +$6.47M
GWPH
87
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.1M 0.26%
73,500
+4,800
+7% +$391K
XNCR icon
88
Xencor
XNCR
$1.59B
$5.03M 0.25%
344,000
-22,600
-6% -$304K
TCON
89
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$4.78M 0.24%
2,589
+569
+28% +$1.14M
CDTX
90
DELISTED
Cidara Therapeutics
CDTX
$4.53M 0.23%
13,200
+4,430
+51% +$1.33M
DRNA
91
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.47M 0.22%
377,000
+61,700
+20% +$706K
VRTX icon
92
Vertex Pharmaceuticals
VRTX
$122B
$4.35M 0.22%
+34,600
New +$4.18M
OMED
93
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4.28M 0.21%
190,000
+43,100
+29% +$883K
ATRC icon
94
AtriCure
ATRC
$2.04B
$4.04M 0.2%
180,000
-4,100
-2% -$84.5K
JUNO
95
DELISTED
Juno Therapeutics, Inc.
JUNO
$3.96M 0.2%
+90,000
New +$4.46M
INSM icon
96
Insmed
INSM
$22B
$3.81M 0.19%
210,000
+65,400
+45% +$1.15M
IMDZ
97
DELISTED
Immune Design Corp.
IMDZ
$3.61M 0.18%
180,000
+25,499
+17% +$439K
QURE icon
98
uniQure
QURE
$2.93B
$2.89M 0.14%
174,900
+20,000
+13% +$371K
CTMX icon
99
CytomX Therapeutics
CTMX
$714M
$2.09M 0.1%
+100,000
New +$1.58M
ARAY icon
100
Accuray
ARAY
$33.9M
$2.07M 0.1%
306,200
-58,400
-16% -$375K
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Eventide Asset Management held 148 positions worth $2B, up 16% from $1.72B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Eventide Asset Management deployed $118M of net new capital in Q4 2015, opening 13 new positions and adding to 87 existing holdings. Its largest new stake was Cirrus Logic: 500,000 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was TerraForm Power, Inc, an estimated $17.7M trimmed.

  • Eventide Asset Management's largest Q4 2015 buy was Cirrus Logic: 500,000 shares worth $14.8M.
  • Eventide Asset Management added most to Athenahealth, Inc. in Q4 2015, an estimated $16.4M increase.
  • Eventide Asset Management's biggest Q4 2015 reduction was TerraForm Power, Inc, cutting an estimated $17.7M.
  • Eventide Asset Management fully exited DYAX CORPORATION in Q4 2015, selling an estimated $27.7M.
  • Eventide Asset Management's ten largest holdings make up 28% of its $2B portfolio in Q4 2015.
  • Eventide Asset Management opened 13 new positions and closed 14 in Q4 2015.
  • Eventide Asset Management's portfolio value rose 16% quarter-over-quarter to $2B.

Based on Eventide Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.